CRISPR and Cas Genes Market Growth and Revenue Forecast Analysis

Expanding clinical applications, rising therapeutic pipeline activity, and accelerating diagnostic adoption are repositioning CRISPR and Cas genes from research tools to revenue-generating platforms, with market value rising from $5.24 billion to $13.4 billion underpinned by a sustained 14.3% compound annual revenue growth profile.